Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021

Эпидемиология злокачественных новообразований желудочно-кишечного тракта: систематический анализ по данным исследования Global Burden of Disease 2021
Lewis Rowland Roberts, Michael B. Fallon, Michael B. Wallace, Ju Dong Yang, Denise M. Harnois, Karn Wijarnpreecha, Pojsakorn Danpanichkul, Yanfang Pang, Kanokphong Suparan, Primrose Tothanarungroj, Krittameth Rakwong, Rashid Nok-Shun Lui, Disatorn Dejvajara, Romelia Barba, Jerapas Thongpiya
2024-09-06

Global Burden of Disease Study 2021Sociodemographic Indexage-standardised death rateage-standardised incidence rategastrointestinal cancers
BACKGROUND: Gastrointestinal cancers comprise nearly one-third of global mortality from cancer, yet the comprehensive global burden of these cancers remains uninvestigated. OBJECTIVE: We aimed to assess the global, regional and national burden of gastrointestinal cancers. DESIGNS: Data on oesophagus, gastric, colorectal, liver, pancreas and biliary tract cancers were extracted from the Global Burden of Disease 2021 database. Age-standardised incidence rate (ASIR) and age-standardised death rate (ASDR) were calculated by sex, region and Sociodemographic Index (SDI). RESULTS: In 2021, there were 5.26 million incidences and 3.70 million deaths from gastrointestinal cancer. The greatest burden is from colorectal, followed by gastric, oesophageal, pancreatic, liver and biliary tract cancer. We noted geographical and socioeconomic differences in ASIR and ASDR across all types of cancers. From 2000 to 2021, ASIR increased for colorectal cancer (annual percent change (APC): 0.10%, 95% CI 0.05% to 0.14%), pancreatic cancer (APC: 0.27%, 95% CI 0.14% to 0.41%), and liver cancer from metabolic dysfunction-associated steatotic liver disease (APC: 0.62%, 95% CI 0.58% to 0.67%) and alcohol-related liver disease (APC: 0.26%, 95% CI 0.22% to 0.30%). ASDR increased for pancreatic cancer (APC: 0.18%, 95% CI 0.02% to 0.34%). Higher SDI countries had higher incidence rates for most types of gastrointestinal cancer. CONCLUSIONS: Although the ASIR of oesophageal, gastric and biliary tract cancer has decreased, the ASIR still increased in colorectal, pancreatic and liver cancer from steatotic liver disease. Public policies are important for controlling gastrointestinal cancers-most importantly, reducing alcohol consumption, hepatitis B immunisation and tackling the burden of metabolic diseases.
1
Age-standardised incidence and death rates varied substantially by geography and socioeconomic development across gastrointestinal cancer types.
2
Colorectal cancer imposed the greatest gastrointestinal cancer burden, followed by gastric, oesophageal, pancreatic, liver and biliary tract cancers.
3
From 2000 to 2021, incidence increased for colorectal, pancreatic, and liver cancers related to metabolic dysfunction-associated steatotic liver disease and alcohol.
4
In 2021, gastrointestinal cancers caused 5.26 million incident cases and 3.70 million deaths globally.
5
Pancreatic cancer mortality increased over the same period, while oesophageal, gastric and biliary tract cancer incidence declined.
6
The findings support policies targeting alcohol reduction, hepatitis B immunisation, and metabolic disease prevention to control gastrointestinal cancers.

Global gastrointestinal cancers, including oesophageal, gastric, colorectal, liver, pancreatic and biliary tract cancers, across global, regional and national populations

The geographical, socioeconomic and temporal patterns of incidence and mortality burden, measured by age-standardised incidence and death rates, by cancer type, sex, region and Sociodemographic Index

Publication Details
Publication Date
2024-09-06
Journal
Publisher
ISSN
Cited by
165
Access Type
Author Information
Authors
Lewis Rowland Roberts
Michael B. Fallon
Michael B. Wallace
Ju Dong Yang
Denise M. Harnois
Karn Wijarnpreecha
Pojsakorn Danpanichkul
Yanfang Pang
Kanokphong Suparan
Primrose Tothanarungroj
Krittameth Rakwong
Rashid Nok-Shun Lui
Disatorn Dejvajara
Romelia Barba
Jerapas Thongpiya
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%